NCT01500486View on ClinicalTrials.gov

Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Growth Hormone DisorderGrowth Hormone Deficiency in ChildrenDelivery Systems
Interventions
DEVICE

NordiFlex PenMate™

Subjects whom will be offered growth hormone (Norditropin NordiFlex®) on prescription as part of normal clinical practice will be asked to evaluate the NordiFlex PenMate™ device.

Trial Locations (4)

55127

Novo Nordisk Investigational Site, Mainz

Unknown

Novo Nordisk Investigational Site, Alphen aan den Rijn

202 15

Novo Nordisk Investigational Site, Malmo

SE-202 15

Novo Nordisk Investigational Site, Malmo

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY